The 15th annual DPHARM: Disruptive Innovations to Modernize Clinical Research (September 16–17, 2025, Philadelphia, PA) brought together senior clinical operations executives, patient advocates, and technology leaders to explore the future of clinical trials. AI, patient-centric trial…
What happens to the human body when gravity disappears? Astronauts experience rapid cardiovascular and vestibular adaptation, which can cause dizziness, fainting, or impaired performance. The Ax-4 mission’s Telemetric Health AI (TESH) study captures these physiological changes…
ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells controlling voluntary muscle movement. Each year, more than 5,000 people in the United States are diagnosed, and around 30,000 people are living…
🏈 Kicking Off Progress in ALS Research – We’re honored to share that TrialX’s global clinical trial finder now powers the ALS Network’s Trial Finder—an AI-driven platform designed to help individuals easily discover clinical trials focused on amyotrophic…
“I get so excited when I read about new treatments and developments in the fight against ovarian cancer. I would love more than anything to one day see a discovery that will prevent this disease altogether….
If we can protect an astronaut’s body in space, how do we safeguard their mind? Space health research is no longer limited to monitoring heart rates or muscle loss. On missions like Axiom-4, astronauts face one…
When Len Gardner was admitted to the NIH Clinical Center in 1955, he joined a clinical study that would ultimately save his life. Diagnosed with a serious kidney condition, he received an experimental drug—now known as…
